Correlation Between KB Financial and Sonoma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both KB Financial and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KB Financial and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KB Financial Group and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on KB Financial and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KB Financial with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of KB Financial and Sonoma Pharmaceuticals.
Diversification Opportunities for KB Financial and Sonoma Pharmaceuticals
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between KB Financial and Sonoma is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding KB Financial Group and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and KB Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KB Financial Group are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of KB Financial i.e., KB Financial and Sonoma Pharmaceuticals go up and down completely randomly.
Pair Corralation between KB Financial and Sonoma Pharmaceuticals
Allowing for the 90-day total investment horizon KB Financial Group is expected to under-perform the Sonoma Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, KB Financial Group is 5.25 times less risky than Sonoma Pharmaceuticals. The stock trades about -0.06 of its potential returns per unit of risk. The Sonoma Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 275.00 in Sonoma Pharmaceuticals on December 30, 2024 and sell it today you would lose (34.00) from holding Sonoma Pharmaceuticals or give up 12.36% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
KB Financial Group vs. Sonoma Pharmaceuticals
Performance |
Timeline |
KB Financial Group |
Sonoma Pharmaceuticals |
KB Financial and Sonoma Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with KB Financial and Sonoma Pharmaceuticals
The main advantage of trading using opposite KB Financial and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KB Financial position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.KB Financial vs. Shinhan Financial Group | KB Financial vs. Woori Financial Group | KB Financial vs. Korea Electric Power | KB Financial vs. Orix Corp Ads |
Sonoma Pharmaceuticals vs. China Pharma Holdings | Sonoma Pharmaceuticals vs. Universe Pharmaceuticals | Sonoma Pharmaceuticals vs. Akanda Corp | Sonoma Pharmaceuticals vs. Petros Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |